JPS63159308A - Hair nourishing cosmetic - Google Patents
Hair nourishing cosmeticInfo
- Publication number
- JPS63159308A JPS63159308A JP30739386A JP30739386A JPS63159308A JP S63159308 A JPS63159308 A JP S63159308A JP 30739386 A JP30739386 A JP 30739386A JP 30739386 A JP30739386 A JP 30739386A JP S63159308 A JPS63159308 A JP S63159308A
- Authority
- JP
- Japan
- Prior art keywords
- hair
- effects
- scalp
- hair nourishing
- blood circulation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 210000004209 hair Anatomy 0.000 title claims abstract description 39
- 239000002537 cosmetic Substances 0.000 title claims abstract description 19
- JBNULYRBVMNPIS-OWJCAWTQSA-L calcium;4-[[(2r)-2,4-dihydroxy-3,3-dimethylbutanoyl]amino]butanoate;hydrate Chemical compound O.[Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCCC([O-])=O JBNULYRBVMNPIS-OWJCAWTQSA-L 0.000 claims abstract description 10
- 229950001260 hopantenic acid Drugs 0.000 claims abstract description 9
- 230000017531 blood circulation Effects 0.000 abstract description 23
- 230000000694 effects Effects 0.000 abstract description 19
- 230000001737 promoting effect Effects 0.000 abstract description 12
- 210000004761 scalp Anatomy 0.000 abstract description 11
- 208000001840 Dandruff Diseases 0.000 abstract description 10
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 abstract description 8
- 239000011575 calcium Substances 0.000 abstract description 8
- 229910052791 calcium Inorganic materials 0.000 abstract description 8
- 206010040880 Skin irritation Diseases 0.000 abstract description 4
- 230000003405 preventing effect Effects 0.000 abstract description 4
- 231100000475 skin irritation Toxicity 0.000 abstract description 4
- 230000036556 skin irritation Effects 0.000 abstract description 4
- 229940079593 drug Drugs 0.000 abstract description 3
- 239000003814 drug Substances 0.000 abstract description 3
- 206010008129 cerebral palsy Diseases 0.000 abstract description 2
- 206010014599 encephalitis Diseases 0.000 abstract description 2
- 239000011159 matrix material Substances 0.000 abstract description 2
- 206010020651 Hyperkinesia Diseases 0.000 abstract 1
- 208000000269 Hyperkinesis Diseases 0.000 abstract 1
- 238000010521 absorption reaction Methods 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000003450 growing effect Effects 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 238000012360 testing method Methods 0.000 description 21
- 230000003779 hair growth Effects 0.000 description 20
- 230000000052 comparative effect Effects 0.000 description 9
- 239000004615 ingredient Substances 0.000 description 9
- 239000000126 substance Substances 0.000 description 8
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 6
- YNBADRVTZLEFNH-UHFFFAOYSA-N methyl nicotinate Chemical compound COC(=O)C1=CC=CN=C1 YNBADRVTZLEFNH-UHFFFAOYSA-N 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 238000010998 test method Methods 0.000 description 6
- 241001465754 Metazoa Species 0.000 description 5
- 239000006071 cream Substances 0.000 description 5
- 238000011156 evaluation Methods 0.000 description 5
- 230000003658 preventing hair loss Effects 0.000 description 5
- 230000008326 skin blood flow Effects 0.000 description 5
- 201000004384 Alopecia Diseases 0.000 description 4
- 230000003247 decreasing effect Effects 0.000 description 4
- 230000002265 prevention Effects 0.000 description 4
- 235000002566 Capsicum Nutrition 0.000 description 3
- 240000008574 Capsicum frutescens Species 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 239000001390 capsicum minimum Substances 0.000 description 3
- 229960001238 methylnicotinate Drugs 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 239000011664 nicotinic acid Substances 0.000 description 3
- 235000001968 nicotinic acid Nutrition 0.000 description 3
- 229960003512 nicotinic acid Drugs 0.000 description 3
- 229940098465 tincture Drugs 0.000 description 3
- 235000015961 tonic Nutrition 0.000 description 3
- 230000001256 tonic effect Effects 0.000 description 3
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 206010068168 androgenetic alopecia Diseases 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 230000003676 hair loss Effects 0.000 description 2
- 208000024963 hair loss Diseases 0.000 description 2
- 210000003128 head Anatomy 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000003449 preventive effect Effects 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 230000002459 sustained effect Effects 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- FERIUCNNQQJTOY-UHFFFAOYSA-M Butyrate Chemical compound CCCC([O-])=O FERIUCNNQQJTOY-UHFFFAOYSA-M 0.000 description 1
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Natural products CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 1
- 208000019300 CLIPPERS Diseases 0.000 description 1
- 229920000298 Cellophane Polymers 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 235000010254 Jasminum officinale Nutrition 0.000 description 1
- 240000005385 Jasminum sambac Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 240000004371 Panax ginseng Species 0.000 description 1
- 235000002789 Panax ginseng Nutrition 0.000 description 1
- 244000184734 Pyrus japonica Species 0.000 description 1
- 206010039792 Seborrhoea Diseases 0.000 description 1
- 241001314440 Triphora trianthophoros Species 0.000 description 1
- YTGLSPCIFCDMGL-UHFFFAOYSA-N [Ca].[Ca].O Chemical compound [Ca].[Ca].O YTGLSPCIFCDMGL-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 229940124277 aminobutyric acid Drugs 0.000 description 1
- 201000002996 androgenic alopecia Diseases 0.000 description 1
- 230000002280 anti-androgenic effect Effects 0.000 description 1
- 239000000051 antiandrogen Substances 0.000 description 1
- 229940030495 antiandrogen sex hormone and modulator of the genital system Drugs 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 208000021930 chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids Diseases 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 239000003410 keratolytic agent Substances 0.000 description 1
- 208000011977 language disease Diseases 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 230000007102 metabolic function Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 231100001067 mild skin irritation Toxicity 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 238000004080 punching Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000000565 sealant Substances 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000013517 stratification Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- 229960000716 tonics Drugs 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/006—Antidandruff preparations
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
Abstract
Description
【発明の詳細な説明】
(技術分野)
本発明は、ホパンテン酸カルシウムを配合してなる養毛
化粧料に関する。更に詳しくは、頭皮の血行を持続的に
促し、育毛効果、脱毛予防効果及びふけ防止効果に優れ
た養毛化粧料に関する。DETAILED DESCRIPTION OF THE INVENTION (Technical Field) The present invention relates to a hair nourishing cosmetic containing calcium hopantenate. More specifically, the present invention relates to a hair nourishing cosmetic that continuously promotes blood circulation in the scalp and has excellent hair growth, hair loss prevention, and dandruff prevention effects.
(従来技術)
従来より、トウガラシチンキ、センブリエキス、朝鮮ニ
ンジンエキス、ニコチン酸、ニコチン酸メチル等の頭皮
の血行促進物質を配合してなる養毛化粧料は良く知られ
ている。(Prior Art) Hair nourishing cosmetics containing scalp blood circulation promoting substances such as capsicum tincture, Jasmine japonica extract, Korean ginseng extract, nicotinic acid, and methyl nicotinate have been well known.
しかし、これら血行促進物質は、皮膚刺激性が強く、そ
の配合量に制約が生じるものであり、血行促進作用が短
時間に減少するもの、または血行促進作用が弱いもので
あり、育毛、脱毛防止、ふけ防止等の効果が充分に発現
する程に有効なる物質ではなかった。However, these blood circulation promoting substances are highly irritating to the skin, and there are restrictions on the amount they can be added.The blood circulation promoting effect decreases in a short period of time, or the blood circulation promoting effect is weak. However, the substance was not effective enough to exhibit sufficient effects such as preventing dandruff.
(発明の開示)
そこで、本発明者は、養毛化粧料に配合して著効のある
血行促進物質に関して、鋭意研究を重ねた結果、ホバン
テン酸カルシウムを配合してなる養毛化粧料は、皮膚刺
激が極めて弱く、頭皮の血行を持続的に促進し、育毛、
脱毛予防及びふけ防止等に優れた効果を有することを見
出し、本発明を完成するに至った。(Disclosure of the Invention) Therefore, as a result of extensive research into blood circulation promoting substances that are effective when incorporated into hair-growth cosmetics, the present inventors found that hair-growth cosmetics containing calcium fobantenate are: Extremely mild skin irritation, continuously promotes blood circulation in the scalp, promotes hair growth,
The present inventors have discovered that the present invention has excellent effects on hair loss prevention, dandruff prevention, etc., and have completed the present invention.
(発明の目的)
本発明の目的は、頭皮の血行を持続的に促進し、育毛、
脱毛予防及びふけ防止等の効果に優れた養毛化粧料を提
供することにある。(Objective of the invention) The object of the present invention is to continuously promote blood circulation in the scalp, promote hair growth,
An object of the present invention is to provide a hair-nourishing cosmetic that is excellent in effects such as preventing hair loss and preventing dandruff.
(発明の構成)
本発明は、ホパンテン酸カルシウムを配合してなる養毛
化粧料である。(Structure of the Invention) The present invention is a hair nourishing cosmetic containing calcium hopanthenate.
(構成の具体的な説明)
本発明に用いるホパンテン酸カルシウムは、公知の物質
であって、その薬理効果としてはブドウ糖の脳内取り込
み及びその代謝を促進させる作用があり、脳炎後遺症や
脳性麻痺などに随伴する多動、注意力低下、言語障害の
治療に有効であり、副作用も少ない薬剤であることが知
られている。(Specific explanation of composition) Calcium hopantenate used in the present invention is a known substance, and its pharmacological effect is to promote the uptake of glucose into the brain and its metabolism, and it can cause symptoms such as encephalitis sequelae and cerebral palsy. It is known to be effective in the treatment of hyperactivity, decreased attention, and language disorders associated with children, and is known to have few side effects.
ホバンテン酸カルシウムに関する化学的性質等は下記の
通りである。The chemical properties of calcium fobantenate are as follows.
(1)構造
(上記構造式のR3はHOCH、基を、R1はN HC
H2CHz CH! C00基を表わす。)(2)化学
名
カルシウムD−(+)−4−(2,4−ジヒドロキシ−
3,3−ジメチル ブチロアマイド)ブチレイト ヘミ
ハイドレイト
Ca l c i um D−(+) −4−(2,
4−dihydroxy−3,3−dimethylb
utyrate hemihydrat(3) P
la名:ホパンテン酸カルシウム(Calcium
hopante
−na t e)
(4)分子式: CzoH3hCa NOs ・’/z
Hz 0(5)分子量:513.60
(6)融点 :155−165°C
本発明の養毛化粧料に配合せるホバンテン酸カルシウム
は、メタノール40m1に金属ナトリウム400n+g
を加え、加温して懸濁溶液とし、これにT−アミノ酪酸
1.2gを加えて溶解した。次いてバントラクトン1.
3gを加えて2時間撹拌の後、−夜装置、溶媒を留去し
析出せる白色結晶に水を加え不溶物を遠沈除去してから
、水を蒸散させ、乾燥後白色結晶状のホバンテン酸カル
シウムを得た。(1) Structure (R3 in the above structural formula is HOCH, R1 is NHC
H2CHz CH! Represents C00 group. ) (2) Chemical name Calcium D-(+)-4-(2,4-dihydroxy-
3,3-dimethyl butyroamide) butyrate hemihydrate Calcium D-(+) -4-(2,
4-dihydroxy-3,3-dimethylb
utyrate hemihydrat (3) P
la name: Calcium hopantenate
(4) Molecular formula: CzoH3hCa NOs ・'/z
Hz 0(5) Molecular weight: 513.60 (6) Melting point: 155-165°C Calcium fobantenate to be added to the hair-growth cosmetic of the present invention is prepared by adding 400n+g of metallic sodium to 40ml of methanol.
was added and heated to form a suspension solution, and 1.2 g of T-aminobutyric acid was added and dissolved therein. Next, Bantolactone 1.
After adding 3 g and stirring for 2 hours, use the apparatus to distill off the solvent, add water to the precipitated white crystals, remove insoluble matter by centrifugation, evaporate the water, and dry the white crystals of hobantenic acid. Obtained calcium.
上記合成法によって得られたホパンテン酸カルシウムを
本発明の諸試験に用いた。Calcium hopantenate obtained by the above synthesis method was used in various tests of the present invention.
また、本発明に用いたホパンテン酸カルシウムは、適度
な経皮吸収性を有するため、頭皮内における該薬物の有
効濃度を持続するものであって、皮膚刺激性も弱く、持
続的な血行促進作用が毛母細胞を賦活して優れた育毛、
脱毛予防効果を発現し、更には、頭皮代謝機能を正常化
して、ふけ防止効果を高めるものと推察される。In addition, the calcium hopantenate used in the present invention has moderate transdermal absorbability, so it maintains an effective concentration of the drug in the scalp, has low skin irritation, and has a sustained blood circulation promoting effect. activates hair matrix cells for excellent hair growth,
It is presumed that it exerts a hair loss preventive effect and further normalizes the scalp metabolic function, thereby increasing the dandruff preventive effect.
ホパンテン酸カルシウムの配合量は、本発明の養毛化粧
料の組成物の全重量に対して0.05〜2.0重量%(
以下wt%と略記する)であればよく、好ましくは0.
1〜1.5wt%である。The blending amount of calcium hopantenate is 0.05 to 2.0% by weight based on the total weight of the hair nourishing cosmetic composition of the present invention.
(hereinafter abbreviated as wt%), preferably 0.
It is 1 to 1.5 wt%.
配合量が0.05wt%未満では、本発明の目的とする
効果に充分でなく、一方2.0wL%を越えても、その
増加分に見合った効果の向上は望めないものである。If the blending amount is less than 0.05 wt%, it is not sufficient to achieve the desired effect of the present invention, and on the other hand, even if it exceeds 2.0 wL%, an improvement in the effect commensurate with the increase cannot be expected.
本発明の養毛化粧料は、常法に従って、ヘアートニフク
、ヘアーローション、ヘアークリーム等の割型にするこ
とが可能である。The hair nourishing cosmetic composition of the present invention can be made into split molds such as hair tonics, hair lotions, hair creams, etc. according to conventional methods.
本発明の養毛化粧料には、色素、香料、殺菌剤、防腐剤
、角質溶解剤、抗アンドロゲン剤、養毛剤、抗酸化剤等
を本発明の目的を達成する範囲内で適宜配合することが
できる。The hair nourishing cosmetic composition of the present invention may contain pigments, fragrances, bactericidal agents, preservatives, keratolytic agents, anti-androgens, hair nourishing agents, antioxidants, etc. as appropriate within the scope of achieving the purpose of the present invention. can.
(実施例)
以下、実施例及び比較例に基づいて本発明の詳細な説明
する。(Examples) Hereinafter, the present invention will be described in detail based on Examples and Comparative Examples.
尚、実施例に記載の皮膚血流量試験法、マウス毛成長促
進効果試験法、ヒト頭髪毛成長促進効果試験法及び実用
試験法を下記に示す。The skin blood flow test method, the mouse hair growth promoting effect test method, the human hair growth promoting effect test method, and the practical test method described in the Examples are shown below.
(1)皮膚血流量試験法
ニューシーラントホワイト系兎家3羽の腹部を別宅し、
18時間絶食させた後、ペンタパルビトールのナトリウ
ム塩を35 m g / k gの割合で静脈注射し麻
酔処置する。(1) Skin blood flow test method The abdomens of three New Sealant White rabbits were separated.
After fasting for 18 hours, the animals are anesthetized by intravenously injecting the sodium salt of pentaparbitol at a rate of 35 mg/kg.
プレートタイプトランスジューサーを腹部の試料塗布部
位(試験部位)上にセロファンテープで固定し、交叉熱
電堆式皮膚血流計(シンエイ社製シンコーダー、201
型)を用いて皮膚血流量(μ■)を測定する。A plate-type transducer was fixed with cellophane tape over the sample application site (test site) on the abdomen, and a cross thermopile type skin blood flow meter (Shinei Co., Ltd. Shincoder, 201) was attached.
Measure the skin blood flow (μ■) using a model (type).
試料は3X2Cmの皮膚部位に対して0.1gを均一に
塗布し、試料塗布前の血流量(CB )と試料塗布後一
定時間後(例えば0.5.1.0.2.0時間後)の血
流量(Ct)を測定し、下記の式により血流量増加率(
%)を算出する。Apply 0.1 g of the sample uniformly to a 3 x 2 cm skin area, and compare the blood flow rate (CB ) before sample application and a certain period of time after sample application (e.g. 0.5, 1, 0, 2.0 hours later). The blood flow rate (Ct) is measured and the blood flow increase rate (Ct) is calculated by the following formula:
%).
試験結果は、3羽の血流量増加率の平均値で示した。The test results were shown as the average value of the blood flow increase rate of the three birds.
Ct−c。Ct-c.
血流量の増加は、クリーム基剤を試料として塗布した場
合でも5〜20%程度の増加率を認められるが、血行促
進作用の顕著な成分を配合した試料を塗布したときは、
40〜80%のごとく増加率が高くなる。An increase in blood flow of about 5 to 20% was observed even when a cream base was applied as a sample, but when a sample containing ingredients with a remarkable blood circulation promoting effect was applied,
The increase rate is as high as 40-80%.
(2)マウス毛成長促進効果試験法
aay系白色マウス(雄・6週令・平均体重35g)の
尾部よりの背部皮膚を電気バリカンで刈った後、脱毛ク
リームにより完全に除毛し、翌日より実施例及び比較例
の各試料を被験部皮膚に毎日朝夕2回、1匹当りO,1
m1l布した。l試料に対して動物は1群10匹を使用
した。(2) Mouse hair growth promotion effect test method After cutting the back skin from the tail of AAY white mice (male, 6 weeks old, average weight 35 g) with electric clippers, the hair was completely removed with hair removal cream, and from the next day. Each sample of Examples and Comparative Examples was applied to the skin of the test subject twice daily in the morning and evening, at a dose of O.1 per animal.
I used ml cloth. For each sample, 10 animals were used per group.
育毛効果の判定は、下記に示す判定基準による肉眼判定
の評価点と、毛長、毛重量を対照群と比較することによ
り行った。The hair growth effect was determined by comparing the visual evaluation score, hair length, and hair weight with the control group according to the criteria shown below.
実験開始後15日目に動物を層殺し判定基準により肉眼
判定し、その評価点を合計し、1匹当りの平均評価点を
求めた。更に、被験部位の皮膚を打ち抜き乾燥した後、
毛重量を測定し、その中の20本の毛の長さについても
測定し、各々の平均値で示した。On the 15th day after the start of the experiment, the animals were visually evaluated according to the stratification criteria, and the evaluation scores were totaled to determine the average evaluation score per animal. Furthermore, after punching out the skin at the test site and drying it,
The weight of the hair was measured, and the lengths of 20 of the hairs were also measured, and the average value of each hair was shown.
育毛効果の評価の判定基準
評価点5 周囲の非抜毛部との境が不明〃 4 毛
成長強度
〃 3 毛成長中度
〃 2 毛成長軽度
〃 l 毛成長掻く軽度
〃 O毛成長認められず
(2)ヒト頭髪毛成長促進試験
男性型脱毛症患者である被試験者10名の頭部の耳の上
5cmの位置の頭部を左右2ケ所に於いて直径1cmの
円形状に剃毛した被験部位に、実施例または比較例の試
料を毎日朝夕2回、約3ml塗布し、無処理の右側と比
較した。効果の判定は、試験開始後28日目に、左右の
被験部位の毛髪各々20本ずつ剃毛し、左側(実施例ま
たは比較例を塗布)の毛20本の長さの平均値(B)を
右側(無処理)の毛20本の長さの平均値(^)で除し
た値を求めて評価した。Judgment criteria for hair growth effect evaluation score 5 Boundary with surrounding non-hair removal area is unclear 4 Hair growth intensity 3 Moderate hair growth 2 Mild hair growth l Slight hair growth O No hair growth observed ( 2) Human hair growth promotion test The head of 10 test subjects who were male pattern baldness patients was shaved in a circular shape with a diameter of 1 cm at two places on the left and right at a position 5 cm above the ear. Approximately 3 ml of the sample of Example or Comparative Example was applied to the site twice a day, morning and evening, and compared with the untreated right side. To judge the effectiveness, on the 28th day after the start of the test, 20 hairs each on the left and right test sites were shaved, and the average length of the 20 hairs on the left side (where Example or Comparative Example was applied) (B) was divided by the average length (^) of the 20 hairs on the right side (untreated) for evaluation.
判定の結果は、被試験者10名の各々の(B)/(A)
平均値で示した。The results of the judgment are (B)/(A) for each of the 10 test subjects.
Shown as average value.
(3)実用試験
男性型脱毛症患者である被試験者20名の頭部に毎日朝
夕2回、連続6ケ月間試料を塗布した後の効果で評価し
た。試験結果は、養毛効果、脱毛予防効果、ふけ防止効
果の各項目に対して、「生毛が剛毛化した或いは生毛が
増加した」、「脱毛・が少な(なった」、「ふけが少な
くなった」と回答した人数で示した。(3) Practical test Samples were applied to the heads of 20 test subjects suffering from androgenetic alopecia twice a day in the morning and evening for 6 consecutive months, and then the effects were evaluated. The test results showed that "grown hair became bristly or increased", "hair loss decreased", and "dandruff was reduced" for each of the following categories: hair growth effect, hair loss prevention effect, and dandruff prevention effect. It is shown by the number of people who answered "It has decreased."
実施例1〜4、比較例1〜4
〔オイリーヘアートニック〕
下記の原料組成に於いて、第1表に記載の如く、各種頭
皮血行促進物質を配合して各々のへアートニックを調製
し、前記の諸試験を実施した。尚、皮膚血流量試験では
試料塗布0.5.1,0.2.0時間後の各々の血流量
増加率を測定した。Examples 1 to 4, Comparative Examples 1 to 4 [Oily hair tonic] Each hair tonic was prepared by blending various scalp blood circulation promoting substances with the following raw material composition as shown in Table 1. The various tests described above were conducted. In the skin blood flow test, the rate of increase in blood flow was measured at 0.5.1 and 0.2.0 hours after application of the sample.
(1)組成
(2)調製法
(B)成分中、ニコチン酸、ニコチン酸メチルは(A)
成分に、トウガラシチンキ、ホパンテン酸カルシウムは
(C)成分に溶解し、(A) 、 (B)成分を各々均
一に溶解した後、(A)成分と(B)成分を混合撹拌分
散し、次いて容器に充填する。使用時には内容物を均一
に振盪分散して使用する。(1) Composition (2) Preparation method (B) Among the ingredients, nicotinic acid and methyl nicotinate are (A)
In the ingredients, capsicum tincture and calcium hopantenate are dissolved in the (C) ingredient, and after each of the (A) and (B) ingredients are uniformly dissolved, the (A) ingredient and the (B) ingredient are mixed and dispersed, and then and fill it into containers. When using, shake and disperse the contents uniformly.
(3)特性
各オイツーへアートニックの諸試験を実施した結果を第
1表に記載した。(3) Characteristics Table 1 shows the results of Artonic tests conducted on each OITSU.
第1表に示す如く、比較例1〜4は血流量増加率が低い
か、または時間を経るに従って血流量増加率が低減する
ものであった。また、比較例2.3.4は皮膚刺激があ
り、ヒト皮膚での試験は不可能であった。As shown in Table 1, in Comparative Examples 1 to 4, the rate of increase in blood flow was low, or the rate of increase in blood flow decreased over time. In addition, Comparative Examples 2.3.4 caused skin irritation, making it impossible to test on human skin.
実施例1〜4の本発明の養毛化粧料は諸試験の全てに亘
って明らかに良好なる結果を示した。The hair nourishing cosmetics of Examples 1 to 4 of the present invention showed clearly good results in all of the various tests.
尚、実施例1〜4はヒト皮膚での諸試験に於いて皮膚刺
激は生じなかった。In Examples 1 to 4, no skin irritation occurred in various tests on human skin.
実施例5〜7、比較例5〜7
(ヘアークリーム〕
実施例1と同様にして各々のへアークリームを調製して
諸試験を実施し、その結果を第1表に記載した。Examples 5 to 7, Comparative Examples 5 to 7 (Hair Cream) Each hair cream was prepared in the same manner as in Example 1 and various tests were conducted, and the results are listed in Table 1.
(2)調製法
(B)成分中、ニコチン酸、ニコチン酸メチルは(A)
成分中に、トウガラシチンキ、ホパンテン酸カルシウム
は(C)成分に溶解し、(^) 、 (B)成分を各々
温度80″Cに加温溶解したものを混合した。(2) Preparation method (B) Among the ingredients, nicotinic acid and methyl nicotinate are (A)
Among the ingredients, capsicum tincture and calcium hopanthenate were dissolved in component (C), and components (^) and (B) each dissolved by heating at a temperature of 80''C were mixed.
次いて撹拌しつつ30″Cまで冷却して各ヘアークリー
ムを調製した。Each hair cream was then prepared by cooling to 30''C while stirring.
(3)特性
第1表に示す如く、本発明の養毛化粧料である実施例5
〜7は、比較例5〜7と比較して持続的な血流量増加率
を示すと共に諸試験に於いても優れた効果を示し、配合
量は0.05〜1,5wt%の範囲で本発明の目的を達
成し得るものであった。(3) Characteristics As shown in Table 1, Example 5 is a hair nourishing cosmetic of the present invention.
-7 showed a sustained blood flow increase rate compared to Comparative Examples 5-7 and also showed excellent effects in various tests, and the compounding amount was in the range of 0.05 to 1.5 wt%. The purpose of the invention could be achieved.
(発明の効果)
以上記載の如く、本発明は、頭皮の血行を持続的に促進
し、育毛、脱毛予防及びふけ防止等の効果に優れると共
に、皮膚刺激性の弱い養毛化粧料を提供することは明ら
かである。(Effects of the Invention) As described above, the present invention provides a hair nourishing cosmetic that continuously promotes blood circulation in the scalp, has excellent effects such as hair growth, hair loss prevention, and dandruff prevention, and is less irritating to the skin. That is clear.
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP30739386A JPH064528B2 (en) | 1986-12-22 | 1986-12-22 | Hair nourishing cosmetics |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP30739386A JPH064528B2 (en) | 1986-12-22 | 1986-12-22 | Hair nourishing cosmetics |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS63159308A true JPS63159308A (en) | 1988-07-02 |
JPH064528B2 JPH064528B2 (en) | 1994-01-19 |
Family
ID=17968509
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP30739386A Expired - Lifetime JPH064528B2 (en) | 1986-12-22 | 1986-12-22 | Hair nourishing cosmetics |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH064528B2 (en) |
-
1986
- 1986-12-22 JP JP30739386A patent/JPH064528B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
JPH064528B2 (en) | 1994-01-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPS62175417A (en) | Hair tonic cosmetic | |
JPS63150210A (en) | Hair-tonic cosmetic | |
JP2559678B2 (en) | Hair nourishing cosmetics | |
JPH04305517A (en) | Hair care cosmetics | |
JPS63132816A (en) | Hair-tonic cosmetic | |
JP2546813B2 (en) | Hair nourishing cosmetics | |
JPS63159308A (en) | Hair nourishing cosmetic | |
JP3522388B2 (en) | Hair growth agent | |
JPS617206A (en) | Cell activator | |
JPS63313715A (en) | Hair growth stimulating composition | |
JPH0676296B2 (en) | Nourishing skin cosmetics | |
JP3193544B2 (en) | Hair restoration cosmetics | |
JPS62192311A (en) | Hair tonic cosmetic | |
JPS62270519A (en) | Hair tonic cosmetic | |
JPH0624943A (en) | Hair-growing agent | |
JP3624318B2 (en) | Hair nourishing agent | |
JPS63196507A (en) | Hair nourishing cosmetic | |
JPH04173722A (en) | Hair tonic cosmetic | |
JPH0248512A (en) | Hair tonic | |
JPS60116616A (en) | Cosmetic | |
JPS62126109A (en) | Hair tonic cosmetic | |
JP2869168B2 (en) | Hair restorer and hair restoration cosmetics containing it | |
JPS62270514A (en) | Hair tonic cosmetic | |
JPS62126110A (en) | Hair tonic cosmetic | |
JPS62138413A (en) | Hair tonic cosmetic |